These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 14862813)
21. [Varying aspects of the sensitivity of the tubercle bacillus to para-acetyl-benzaldehyde-thiosemicarbazone (TbI) in Youmans medium]. RIST N; CALS S; JULLIEN W Ann Inst Pasteur (Paris); 1951 Sep; 81(3):324-8. PubMed ID: 14894892 [No Abstract] [Full Text] [Related]
22. [Experiments on combined therapeutic use of streptomycin, conteben and PAS; erythrocyte modifications due to conteben]. MOESCHLIN S; DEMIRAL B Helv Med Acta; 1950 Oct; 17(4-5):568-71. PubMed ID: 14793861 [No Abstract] [Full Text] [Related]
23. [Practical viewpoints of resistance against streptomycin, PAS, conteben]. UNHOLTZ K Tuberkulosearzt; 1952 Aug; 6(8):451-9. PubMed ID: 13005732 [No Abstract] [Full Text] [Related]
24. [Combined conteben and PAS therapy of pulmonary tuberculosis]. HANTSCHMANN L; WERNER R Arztl Wochensch; 1950 Jul; 5(29):525-8. PubMed ID: 15432230 [No Abstract] [Full Text] [Related]
25. [Results of tuberculostatic substances, particularly conteben, in the treatment of 200 cases of osteoarticular tuberculosis]. MAY R Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(4):317-37. PubMed ID: 14847986 [No Abstract] [Full Text] [Related]
26. [Present status of tuberculosis therapy with conteben, a substance of the thiosemicarbazones group]. Rev Bras Tuberc Doencas Torac; 1950; 18(128):173-89. PubMed ID: 14781490 [No Abstract] [Full Text] [Related]
27. [Binding capacity of serum iodine in pulmonary tuberculosis during treatment with TbI-698 (conteben); a contribution to the significance of unsaturated fatty acids and to the mechanism of the therapeutic action of TbI in pulmonary tuberculosis]. JENTGENS H; BREDE HD Munch Med Wochenschr; 1950 Aug; 92(19-20):766-7. PubMed ID: 14775625 [No Abstract] [Full Text] [Related]
29. [Conteben, PAS and streptomycin therapy of tuberculosis in children]. BRUGGER H Munch Med Wochenschr; 1950 Aug; 92(19-20):738-46. PubMed ID: 14775621 [No Abstract] [Full Text] [Related]
30. [Treatment of the otorhinolaryngological localizations of tuberculosis with thiosemicarbazones (conteben)]. STACHOWSKY L Rev Sanid Asist Soc; 1955; 20(5-6):319-38. PubMed ID: 13350962 [No Abstract] [Full Text] [Related]
31. [Conteben therapy in childhood tuberculosis]. RUSS E Kinderarztl Prax; 1950; 18(11-12):521-5. PubMed ID: 14814791 [No Abstract] [Full Text] [Related]
32. [Comparative effect of conteben and PAS in pulmonary tuberculosis therapy]. RAXELL R Sven Lakartidn; 1951 Aug; 48(31):1829-41. PubMed ID: 14866798 [No Abstract] [Full Text] [Related]
33. [Tuberculosis of the rectum and conteben therapy]. SITT W Munch Med Wochenschr; 1950 Sep; 92(21-22):844-5. PubMed ID: 14780046 [No Abstract] [Full Text] [Related]
34. [Roentgen control of the effectiveness of conteben therapy in pulmonary tuberculosis]. HEINE F Dtsch Med Wochenschr; 1951 Feb; 76(8):240-5. PubMed ID: 14822706 [No Abstract] [Full Text] [Related]
35. [Conteben therapy of tuberculosis, with special reference to cutaneous tuberculosis]. WAGNER G Acta Derm Venereol; 1951; 31(4):482-4. PubMed ID: 14856594 [No Abstract] [Full Text] [Related]
36. [Chemotherapy of tuberculosis with conteben and PAS]. FRAHM H Z Tuberk; 1950; 96(1-2):5-14. PubMed ID: 14818387 [No Abstract] [Full Text] [Related]
37. [Conteben therapy of tuberculosis]. KUTSCHERA-AICHBERGEN H Wien Med Wochenschr; 1951 Mar 10-17; 101(10-17):177-81. PubMed ID: 14836677 [No Abstract] [Full Text] [Related]